Micafungin is more active against Candida albicans biofilms with high metabolic activity

Molecular Identification and Antifungal Susceptibility of Yeast Isolates Causing Fungemia Collected in a Population-Based Study in Spain in 2010 and 2011

(2013) Jesús Guinea et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Species-Specific and Drug-Specific Differences in Susceptibility of Candida Biofilms to Echinocandins: Characterization of Less Common Bloodstream Isolates

(2013) Maria Simitsopoulou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

(2013) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Antifungal Lock Therapy

(2012) Carla J. Walraven et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)*

(2012) Maiken C. Arendrup et al.   CLINICAL MICROBIOLOGY AND INFECTION

Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey

(2012) J. Peman et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Effects of Fluconazole, Amphotericin B, and Caspofungin on Candida albicans Biofilms under Conditions of Flow and on Biofilm Dispersion

(2011) Priya Uppuluri et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro assessment of the antifungal and paradoxical activity of different echinocandins against Candida tropicalis biofilms

(2011) T. S. N. Ku et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Early Removal of Central Venous Catheter in Patients with Candidemia Does Not Improve Outcome: Analysis of 842 Patients from 2 Randomized Clinical Trials

(2010) Marcio Nucci et al.   CLINICAL INFECTIOUS DISEASES

In Vitro Activity of Micafungin against Planktonic and Sessile Candida albicans Isolates

(2009) M. J. Jacobson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Biofilm Formation and Effect of Caspofungin on Biofilm Structure of Candida Species Bloodstream Isolates

(2009) J. A. G. Ferreira et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

In vitro analysis of the occurrence of a paradoxical effect with different echinocandins and Candida albicans biofilms

(2009) Marisa H. Miceli et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Biofilm formation in clinical Candida isolates and its association with virulence

(2009) Fahmi Hasan et al.   MICROBES AND INFECTION

EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts

(2008) J.L. Rodriguez-Tudela et al.   CLINICAL MICROBIOLOGY AND INFECTION

A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing

(2008) Christopher G Pierce et al.   Nature Protocols